| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Drug ineffective | FAERS: 35 | US FAERS | |
| 2 | No adverse event | FAERS: 7 | US FAERS | |
| 3 | Product measured potency issue | FAERS: 7 | US FAERS | |
| 4 | Urticaria | FAERS: 3 | US FAERS | |
| 5 | Pruritus | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 6 | Angioedema | FAERS: 1 | US FAERS | |
| 7 | Antinuclear antibody increased | FAERS: 1 | US FAERS | |
| 8 | Arthralgia | FAERS: 1 | US FAERS | |
| 9 | Blood glucose increased | FAERS: 1 | US FAERS | |
| 10 | Blood immunoglobulin G increased | FAERS: 1 | US FAERS | |
| 11 | Dizziness | FAERS: 1 | US FAERS | |
| 12 | Fatigue | FAERS: 1 | US FAERS | |
| 13 | Flushing | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 14 | Headache | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 15 | Hypersensitivity | FAERS: 1 | US FAERS | |
| 16 | Injection site joint pain | FAERS: 1 | US FAERS | |
| 17 | Joint swelling | FAERS: 1 | US FAERS | |
| 18 | Lip swelling | FAERS: 1 | US FAERS | |
| 19 | Nausea | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 20 | Rheumatoid Arthritis | FAERS: 1 | US FAERS | |
| 21 | Injection Site Reaction | Canada Vigilance: 1 | Canada Vigilance | |
| 22 | Malaise | Canada Vigilance: 1 | Canada Vigilance | |
| 23 | Pain | Canada Vigilance: 1 | Canada Vigilance | |
| 24 | Vomiting | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.